Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJun 10, 2020Dextroamphetamine SaccharateSome bottles may contain mixed strengths of the product.Teva Pharmaceuticals USA · D-1285-2020Class IITerminatedJun 10, 2020Estriol USP Micronized 5 GFailed impurities/ degradation specifications: Out of specification for organic impurities.Triova Pharmaceuticals LLC · D-1284-2020Class IIITerminatedJun 3, 2020Lamotrigine TabletsPresence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.Jubilant Cadista Pharmaceuticals, Inc. · D-1281-2020Class IIOngoingJun 3, 2020Maximum Strength Lidocaine Cold & Hot PatchCGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification...Wuhan Bingbing Pharmaceutical Co., Ltd. · D-1280-2020Class IIOngoingJun 3, 2020MencaineCGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification...Wuhan Bingbing Pharmaceutical Co., Ltd. · D-1279-2020Class IIOngoingJun 3, 2020LidoProCGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification...Wuhan Bingbing Pharmaceutical Co., Ltd. · D-1278-2020Class IIOngoingJun 3, 2020LidoPatchCGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification...Wuhan Bingbing Pharmaceutical Co., Ltd. · D-1277-2020Class IITerminatedJun 3, 2020Doxycycline Hyclate tablets USPFailed dissolution specificationsPD-Rx Pharmaceuticals, Inc. · D-1276-2020Class IITerminatedJun 3, 2020Doxycycline Hyclate Tablets USPFailed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.West-Ward Columbus Inc · D-1274-2020Class IIITerminatedMay 27, 2020Ethacrynic Acid Tablets USPFailed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.West-Ward Columbus Inc · D-1282-2020Class IIITerminatedMay 27, 2020Gabapentin Tablets USPFailed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.InvaGen Pharmaceuticals, Inc. · D-1272-2020Class IITerminatedMay 27, 2020AloprimDiscoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of...Mylan Institutional LLC · D-1271-2020Class ITerminatedMay 27, 2020LACTATED RINGER'S InjectionPresence of Particulate Matter: confirmed customer complaint for the presence of particulate matter identified as iron oxide.ICU Medical Inc · D-1270-2020Class ITerminatedMay 20, 2020Finasteride Plus 1.25 mg CapsuleCross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.MasterPharm LLC · D-1269-2020Class IIITerminatedMay 20, 2020ChapStick Total Hydration Moisture + Tint + SPF15 Pretty in Pink Net Wt. 0.08 OZLabeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer cardGlaxosmithkline Consumer Healthcare Holdings · D-1268-2020Class IIITerminatedMay 20, 2020ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry Net Wt. 0.08 OZLabeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer cardGlaxosmithkline Consumer Healthcare Holdings · D-1267-2020Class IIITerminatedMay 20, 2020ChapStick Total Hydration Moisture + Tint + SPF15 Peachy Keen Net Wt. 0.08 OZLabeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer cardGlaxosmithkline Consumer Healthcare Holdings · D-1266-2020Class IIITerminatedMay 20, 2020Memantine Hydrochloride Extended-Release CapsulesFailed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.The Harvard Drug Group · D-1262-2020Class IITerminatedMay 13, 2020Epinephrine Injection USPCGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.Teva Pharmaceuticals USA · D-1260-2020Class IITerminatedMay 13, 2020Infuvite PEDiatric PharmacyDefective Container: Sub-optimal crimping in vial of Pediatric Infuvite Multiple VitaminsSandoz, Inc · D-1259-2020Class ITerminatedMay 6, 2020Ceftazidime for Injection USP and Dextrose for Injection USPFailed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.B. Braun Medical Inc · D-1257-2020Class IIITerminatedMay 6, 2020Esomeprazole Magnesium Delayed Release Capsules USPDiscoloration: product contains brown pelletsDr. Reddy's Laboratories, Inc. · D-1256-2020Class IITerminatedMay 6, 2020Nizatidine Oral SolutionCGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.Amneal Pharmaceuticals of New York, LLC · D-1253-2020Class IITerminatedApr 29, 2020Cefixime for Oral Suspension USPSubpotent Drug: low out of specification (OOS) test result observed in long term stability study.Lupin Pharmaceuticals Inc. · D-1252-2020Class IITerminatedApr 29, 2020PEPPERMINT LIP MOISTURIZERSuperpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.Yusef Manufacturing Laboratories, LLC · D-1251-2020Class IITerminatedApr 29, 2020Lisinopril Tablets USPProduct Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.Lupin Pharmaceuticals Inc. · D-1250-2020Class IITerminatedApr 29, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1249-2020Class IITerminatedApr 29, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1248-2020Class IITerminatedApr 29, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1247-2020Class IITerminatedApr 22, 2020Acetaminophen and Codeine Phosphate 300/30 mg tabletcGMP DeviationsH J Harkins Company Inc dba Pharma Pac · D-1246-2020Class IITerminatedApr 22, 2020EstradiolcGMP deviations: Presence of foreign material (Teflon)introduced at the production level.B & B Pharmaceuticals, Inc. · D-1244-2020Class IITerminatedApr 22, 2020DermatoneMicrobial contamination of non-sterile products: positive test for yeast and bacteria.Filltech USA, LLC · D-1242-2020Class IITerminatedApr 22, 2020DermatoneMicrobial contamination of non-sterile products: positive test for yeast and bacteria.Filltech USA, LLC · D-1241-2020Class IITerminatedApr 22, 2020Losartan Potassium TabletsCGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.Golden State Medical Supply Inc. · D-1238-2020Class IITerminatedApr 22, 2020Oxycodone and Acetaminophen TabletsCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1237-2020Class IITerminatedApr 22, 2020Phentermine Hydrochloride CapsulesCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1236-2020Class IITerminatedApr 22, 2020Mirtazapine TabletsCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1235-2020Class IITerminatedApr 22, 2020Simvastatin TabletsCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1234-2020Class IITerminatedApr 22, 2020Levetiracetam Tablets USP 750 mgCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1233-2020Class IITerminatedApr 22, 2020Gabapentin CapsulesCGMP Deviations: Products were manufactured in a processing area in which water leakage was observedAurobindo Pharma USA Inc. · D-1232-2020

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.